A New Direction for U.S. AI Policy ?An International Bioethical Deliberation - February 2025
- Responsible AI in Medicine Initiative
- Sep 24, 2025
- 1 min read
Brief: As U.S. AI policy seems to change direction with regulatory barriers being removed in favour of an innovation-driven approach, the webinar will explore the possible implications of these changes, focusing on responsibility in the medical field. How should responsible AI in medicine be translated into a regulatory approach? The speakers, all well acquainted with various legal systems, will deliberate on these contemporary issues, and other participants are encouraged to share their questions.
Participents:
Prof. I. Glenn Cohen, Harvard Law School A U.S. Legal Perspective.
Prof. Vera Lúcia Raposo, NOVA School of Law An EU Legal Perspective.
Tamar Tavory, PhD Candidate, Bar-Ilan University An Israeli Legal Perspective.
Panel Discussion and Q&A
Moderator: Dr. Oren Asman, Tel Aviv University.
Comments